UFP Technologies, Inc. (NASDAQ:UFPT) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 4.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,048 shares of the industrial products company’s stock after selling 499 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.14% of UFP Technologies worth $3,499,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Wasatch Advisors LP boosted its position in shares of UFP Technologies by 65.4% in the third quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after acquiring an additional 166,262 shares during the last quarter. Eagle Asset Management Inc. acquired a new position in shares of UFP Technologies in the 3rd quarter valued at $9,791,000. Franklin Resources Inc. grew its stake in shares of UFP Technologies by 39.4% during the 3rd quarter. Franklin Resources Inc. now owns 92,053 shares of the industrial products company’s stock valued at $28,904,000 after buying an additional 26,001 shares during the period. De Lisle Partners LLP increased its holdings in shares of UFP Technologies by 30.6% during the 3rd quarter. De Lisle Partners LLP now owns 66,573 shares of the industrial products company’s stock worth $21,070,000 after buying an additional 15,603 shares during the last quarter. Finally, Millennium Management LLC raised its position in shares of UFP Technologies by 78.8% in the 2nd quarter. Millennium Management LLC now owns 26,706 shares of the industrial products company’s stock worth $7,047,000 after buying an additional 11,767 shares during the period. 87.28% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com raised UFP Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday.

UFP Technologies Price Performance

UFP Technologies stock opened at $265.04 on Friday. The firm has a fifty day moving average of $275.61 and a 200-day moving average of $299.98. UFP Technologies, Inc. has a 52-week low of $152.43 and a 52-week high of $366.41. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $2.03 billion, a P/E ratio of 37.81 and a beta of 1.04.

Insider Buying and Selling at UFP Technologies

In other UFP Technologies news, CEO R Jeffrey Bailly sold 12,533 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total transaction of $4,342,183.18. Following the sale, the chief executive officer now owns 31,194 shares in the company, valued at $10,807,473.24. This represents a 28.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Jason Holt sold 146 shares of UFP Technologies stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total value of $50,032.74. Following the completion of the transaction, the vice president now owns 6,721 shares of the company’s stock, valued at approximately $2,303,219.49. The trade was a 2.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,326 shares of company stock valued at $4,620,154 in the last three months. Corporate insiders own 6.17% of the company’s stock.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.